Description

Overview

Tirzepatide is a dual GIP and GLP-1 receptor agonist that improves insulin sensitivity and weight loss, combined with Methylcobalamin for additional metabolic benefits.

Mechanism of Action

Tirzepatide enhances insulin release, slows digestion, and reduces food intake, while Methylcobalamin supports nerve health and energy metabolism.

Benefits and Indications

• Superior Weight Loss: More effective than semaglutide in clinical trials.
• Improved Insulin Sensitivity: Reduces insulin resistance.

Possible Side Effects

• Nausea, diarrhea
• Fatigue

Drug Interactions

• Other Antidiabetic Medications: Increased risk of low blood sugar.